Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Roger B Cohen,

Roger B Cohen

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology-Oncology
Department of Medicine
University of Pennsylvania School of Medicine
Philadelphia, PA 19104
Office: 2156624469
Education:
A.B. (Biochemical Sciences)
Harvard College (magna cum laude), 1976.
M.D. (Medicine)
Harvard Medical School, 1980.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

Naing, A, Cohen, R, Dy, GK, Hong, DS, Dyster, L, Hangauer, DG, Kwan, R, Fetterly, G, Kurzrock, R, Adjei, AA: A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies. investigational new drugs 31(4): 967-973, AUG 2013.

Weinblatt, ME, Moreland, LW, Westhovens, R, Cohen, RB, Kelly, SM, Khan, N, Pappu, R, Delaet, I, Luo, A, Gujrathi, S, Hochberg, MC: Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program. journal of rheumatology 40(6): 787-797, JUN 2013.

Cohen Roger B, Aamdal Steinar, Nyakas Marta, Cavallin Maria, Green Darron, Learoyd Maria, Smith Ian, Kurzrock Razelle: A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies. European journal of cancer (Oxford, England : 1990) 49(7): 1521-9, Feb 2013.

Meropol Neal J, Egleston Brian L, Buzaglo Joanne S, Balshem Andrew, Benson Al B, Cegala Donald J, Cohen Roger B, Collins Michael, Diefenbach Michael A, Miller Suzanne M, Fleisher Linda, Millard Jennifer L, Ross Eric A, Schulman Kevin A, Silver Allison, Slater Elyse, Solarino Nicholas, Sulmasy Daniel P, Trinastic Jonathan, Weinfurt Kevin P: A Web-based communication aid for patients with cancer: The CONNECT Study. Cancer 119(7): 1437-45, Jan 2013.

Marshall John, Hwang Jimmy, Eskens Ferry A L M, Burger Herman, Malik Shakun, Uttenreuther-Fischer Martina, Stopfer Peter, Ould-Kaci Mahmoud, Cohen Roger B, Lewis Nancy L: A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors. Investigational new drugs 31(2): 399-408, Nov 2012.

Martin L P, Kozloff M F, Herbst R S, Samuel T A, Kim S, Rosbrook B, Tortorici M, Chen Y, Tarazi J, Olszanski A J, Rado T, Starr A, Cohen R B: Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours. British journal of cancer 107(8): 1268-76, Oct 2012.

Weinfurt Kevin P, Seils Damon M, Lin Li, Sulmasy Daniel P, Astrow Alan B, Hurwitz Herbert I, Cohen Roger B, Meropol Neal J: Research Participants' High Expectations of Benefit in Early-Phase Oncology Trials: Are We Asking the Right Question? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 30(35): 4396-400, Oct 2012.

Kozloff M F, Martin L P, Krzakowski M, Samuel T A, Rado T A, Arriola E, De Castro CarpeƱo J, Herbst R S, Tarazi J, Kim S, Rosbrook B, Tortorici M, Olszanski A J, Cohen R B: Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours. British journal of cancer 107(8): 1277-85, Oct 2012.

Dees E Claire, Cohen Roger B, von Mehren Margaret, Stinchcombe Thomas E, Liu Hua, Venkatakrishnan Karthik, Manfredi Mark, Fingert Howard, Burris Howard A, Infante Jeffrey R: Phase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral Formulations. Clinical cancer research : an official journal of the American Association for Cancer Research 18(17): 4775-84, Sep 2012.

Patel Sapna P, Lazar Alexander J, Papadopoulos Nicholas E, Liu Ping, Infante Jeffrey R, Glass Michelle R, Vaughn Carol S, Lorusso Patricia M, Cohen Roger B, Davies Michael A, Kim Kevin B: Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma. Cancer 119(4): 799-805, Sep 2012.

back to top
Last updated: 09/09/2014
The Trustees of the University of Pennsylvania